NEWPORT BEACH, Calif., June 2, 2021 /PRNewswire/ — Vital Data Technology, a data science-driven healthcare solutions leader, today announced the expansion of their Affinitē Risk Adjustment (RA) solution. With additional capabilities, Affinitē RA is a complete risk adjustment solution with suspect logic to ensure an accurate assessment of risk scores, giving payers a complete financial picture of their population.
“We’re spending more on healthcare than ever and the COVID-19 pandemic just accelerated the need for rapid innovation,” commented Matt D’Ambrosia, President and CEO of Vital Data Technology. “Plans need to reduce costs and provider abrasion as much as possible, but a lot of existing solutions are delivering less return on investment as the needs of the market continue to ramp up. We wanted to enhance the capabilities of Affinitē Risk Adjustment so payers get a true end-to-end solution with advanced analytics.”
Affinitē RA has embedded real-time advanced analytics that enable the plan to identify those records with the most potential to improve risk score opportunities and streamline the chart retrieval, coding, and encounters submission process. The real-time reporting package gives payers the visibility and insight needed to prioritize their prospective interventions and project mid-year and final risk scores.
“Existing solutions support the operational, transactional aspects of risk adjustment such as chart retrieval and coding. Affinitē RA, on the other hand, streamlines processes to free up risk adjustment teams to focus on strategic priorities,” explained Peter Janelle, Director of Risk Adjustment for Vital Data Technology. “Eliminating much of the time-consuming manual input, gap analysis, remediation, and provider outreach is key to allocating resources that can improve risk scores and go beyond just maintaining them.”
Affinitē Risk Adjustment is a segment of the Affinitē Platform, alongside Affinitē Quality Improvement and Care Management. By lowering the barriers between risk, quality, and care management, payers can utilize quality and care gap insights for advanced risk assessment. With an integrated data structure involving other lines of business, Affinitē RA provides increased interoperability that payers need today to execute in-house risk adjustment and deliver higher returns on investment.
For more information on Affinitē Risk Adjustment, click here or reach out directly to info@vitaldatatechnology.com.
About Vital Data Technology
Vital Data Technology is transforming the healthcare ecosystem by empowering healthcare stakeholders with prescriptive insights to improve member health and lower costs. Vital Data Technology leverages embedded, real-time data science, Ai, and analytics together to drive intelligent automation through their cloud-based Affinitē platform. Affinitē connects all data sources to align quality, risk, utilization management, and care management solutions and acts as a single source of truth for all healthcare information. With Affinitē as a single source of truth, all healthcare parties can coordinate more efficient care interventions with a true 360-degree view of the member. For more information, go to www.vitaldatatech.com, contact them via email, or follow them on LinkedIn.
Media Contact:
Jerrica Sibley
Vital Data Technology, Marketing & Communications
(866) 482-8399 x 719
311202@email4pr.com
www.vitaldatatech.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/vital-data-technology-expands-affinit-risk-adjustment-into-a-complete-end-to-end-solution-301303876.html
SOURCE Vital Data Technology
Incremental Product Launch Addresses $3.3 Billion North American Functional Tea Market Opportunity with First SuperFood…
DehydraTECH-processed tirzepatide from Zepbound® is being tested in an oral dose format KELOWNA, BC /…
Poster presented at the 29th Annual Meeting of the Society for Neuro-Oncology (SNO 2024)Primary analysis…
CHAGRIN FALLS, OH / ACCESSWIRE / November 25, 2024 / S4 Medical Corp, an Ohio…
NEW YORK, NY / ACCESSWIRE / November 25, 2024 / Acreage Holdings, Inc. ("Acreage" or…